Literature DB >> 23108525

[External beam radiotherapy in the treatment of prostate cancer].

D Böhmer1.   

Abstract

Prostate cancer represents the most frequently diagnosed malignant tumor in Germany. Primary radiotherapy is one of the two recommended curative treatment options for this disease. There are two types of radiotherapy: external beam radiotherapy and interstitial brachytherapy. Technical developments during the last two decades have made it possible to achieve improved chances of being cured of tumors and improved relief from disease-related symptoms for patients at all tumor stages. Moreover, treatment can be administered with a reduced rate of side effects. Results of classical 3D conformal radiotherapy as well as modern radiation therapy techniques are comprehensively presented including the concept of hypofractionation with results from available randomized trials. After comprehensive assessment of all relevant risk factors, recommendations for the type of treatment must be based on a multidisciplinary approach.

Entities:  

Mesh:

Year:  2012        PMID: 23108525     DOI: 10.1007/s00120-012-3017-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

1.  Human collagen injections to reduce rectal dose during radiotherapy.

Authors:  William R Noyes; Charles C Hosford; Steven E Schultz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-22       Impact factor: 7.038

2.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; J Fondurulia; M H Chen; I Kaplan; C J Beard; J E Tomaszewski; A A Renshaw; A Wein; C N Coleman
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

3.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer.

Authors:  J Lattanzi; S McNeeley; W Pinover; E Horwitz; I Das; T E Schultheiss; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

4.  70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

Authors:  Véronique Beckendorf; Stéphane Guerif; Elisabeth Le Prisé; Jean-Marc Cosset; Agnes Bougnoux; Bruno Chauvet; Naji Salem; Olivier Chapet; Sylvain Bourdain; Jean-Marc Bachaud; Philippe Maingon; Jean-Michel Hannoun-Levi; Luc Malissard; Jean-Marc Simon; Pascal Pommier; Men Hay; Bernard Dubray; Jean-Léon Lagrange; Elisabeth Luporsi; Pierre Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

5.  Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Authors:  Anthony L Zietman; Kyounghwa Bae; Jerry D Slater; William U Shipley; Jason A Efstathiou; John J Coen; David A Bush; Margie Lunt; Daphna Y Spiegel; Rafi Skowronski; B Rodney Jabola; Carl J Rossi
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

6.  Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study.

Authors:  Laurence E Court; Lei Dong; Noah Taylor; Matthew Ballo; Kei Kitamura; Andrew K Lee; Jennifer O'Daniel; R Allen White; Rex Cheung; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

7.  Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Authors:  Abrahim Al-Mamgani; Wim L J van Putten; Wilma D Heemsbergen; Geert J L H van Leenders; Annerie Slot; Michel F H Dielwart; Luca Incrocci; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

8.  Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.

Authors:  Hans T Chung; Ping Xia; Linda W Chan; Eileen Park-Somers; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-22       Impact factor: 7.038

9.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Authors:  Michael J Zelefsky; Marisa Kollmeier; Brett Cox; Anthony Fidaleo; Dahlia Sperling; Xin Pei; Brett Carver; Jonathan Coleman; Michael Lovelock; Margie Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

10.  Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy.

Authors:  Reinhold Graf; Peter Wust; Volker Budach; Dirk Boehmer
Journal:  Radiat Oncol       Date:  2009-04-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.